Login to Your Account



Cell Pathways’ Exisulind Lowers PSA Levels In Phase II/III Trial


Friday, May 7, 1999
No Abstract

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription